Premia and National Cancer Center Hospital East Announce the Initiation of the LC-SCRUM-AP Genomic..

Updated: Dec 23, 2022

Establishing a large-scale lung cancer genomic screening platform in the Asia-Pacific region and promoting precision medicine for lung cancer.

Read the full press release below:

Recent Posts

TOKYO and XIAMEN, March 27, 2025 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd. (“AmoyDx”), and Precision Medicine Asia Co., Ltd....

TOKYO and XIAMEN, February 6th, 2025 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd. (“AmoyDx”), and Precision Medicine Asia Co.,...

The National Cancer Center (“NCC”), Precision Medicine Asia Co., Ltd. (“PREMIA”) and Paradigm Health Inc (“Paradigm”), announced the...